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Introduction: Bladder augmentation through tissue engineering
currently involves autologous tissue transplantation, e.g. insertion
of small intestinal tissue. We evaluated four acellular collagen
biomatrices for bladder wall regeneration in a rabbit model.
Material & Methods: Rabbits underwent bladder wall augmen-
tation with a circular biochemically deﬁned single (SL) or dual
layer (DL) collagen biomatrix. The SL or DL matrices were com-
posed of collagen (COL)þ heparin (HEP) or COLþHEPþ
Growth Factors (GF). The following GF were used: Epithelial
Growth Factor (EGF), Vascular Epithelial Growth Factor (VEGF)
and b-Fibroblast Growth Factor (b-FGF). The regenerated bladder
walls were harvested at 2, 4 and 12 weeks after implantation.
Tissue regeneration was evaluated using routine histology.
Results: Biomatrix encrustation was observed in 30/48 (63%)
of animals. All biomatrices showed considerable inﬂux of in-
ﬂammatory cells in the ﬁrst 4 weeks, gradual decreasing in time.
At all time points, we found collagen remnants in the regenerated
bladder. The SL-HEP-GF, DL-HEP and DL-HEP-GF matrices
showed earlier epithelialization and neovascularization in com-
parison with the SL-HEP biomatrix at 2 weeks. In the biomatrices
with growth factors, only single muscle cells were present at the
peripheral area of the regenerated graft material at 12 weeks.
Conclusions: Tissue regeneration velocity was higher with
the use of dual layer or Growth Factors-modiﬁed biomatrices.
This clearly shows that bioactive modiﬁcations with the use of
special coatings and growth factors improves bladder wall regen-
eration for tissue engineering. The dual-layer biomatrix containing
heparin and growth factors have a high capacity for bladder re-
generation.
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Engineering a blood vessel requires an understanding of the pa-
rameters governing the survival of resident vascular smooth
muscle cells. We have developed an in vitro collagen-based vas-
cular media model to test the correlation between cell density, O2
requirements and cell viability.
Collagen type I constructs seeded with porcine Pulmonary Ar-
tery Smooth Muscle Cells (PASMCs) at different densities, low
(11106 cells/ml) and high (23106 cells/ml) were compressed to
produce 100 mm thick, dense collagen sheets. These were subse-
quently spiraled around a mandrel to mimic tubular structures and
cultured for up to 72 hrs in vitro under static conditions. O2 levels
were quantiﬁed in the core of these constructs and correlated to cell
viability.
The starting O2 level was 140mmHg.Within 24 hours O2 levels
in the core of constructs with low cell density dropped to
80mmHg. For the high cell density, levels dropped to 10mmHg
and remained at this level for up to 3 days. Cell viability in high
density constructs was 99% at 24 hrs both in the core and on the
surface. This decreased to 80% ( p< 0.05) in the core after 3 days,
but remained high (95%) on the surface, indicating that physio-
logical hypoxia might reduce cell viability. At low cell density,
increasing diffusion distance by 33% (increasing collagen layers)
resulted in a signiﬁcant reduction of core O2 levels to 50mmHg
within 24 hrs (p< 0.05).
This study provides a useful model for examining physiological
parameters dictating vascular smooth muscle cell survival and
behaviour in engineered vascular structures.
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In the biomaterials ﬁeld, nanoﬁbre based structures and its com-
posites are promising materials to produce scaffolds mimicking
the architecture of the extracellular matrix (ECM). The main
purpose of this work was to develop a novel composite structure
which combines polymeric microﬁbres reinforced by nanoﬁbres.
This combination was obtained by melting extrusion of a com-
posite with a natural polymer, Chitosan particles, and a biode-
gradable polymer, poly(butylene succinate) (50:50 wt), reinforced
with chitosan nanoﬁbre meshes (0.05% wt). The chitosan meshes
were produced by electrospinning. The nanoﬁbre reinforced mi-
croﬁbres were analysed by SEM demonstrated a considerable
alignment of the nanoﬁbres along the longitudinal axis of the mi-
croﬁbres.
Tensile mechanical properties revealed that the introduction of
the reinforcement in the microﬁbres composite increased the ten-
sile modulus until 295.7 16.2MPa. This improvement is around
70% since the tensile modulus of microﬁbres without the nanoﬁbre
reinforcement was 175.6 32.7MPa. Various structures were
subjected to swelling and degradation tests, in an isotonic saline
solution at 378C. The presence of chitosan nanoﬁbres in the mi-
croﬁbres enhanced the water uptake in up to 24%. The weight loss
was also increased, reaching a maximum of 7.4% at the third day of
the degradation tests.
The combination of good mechanical properties and enhanced
degradability of the developed ﬁbres may have a great potential to
produce 3D ﬁber meshes scaffolds.
Human bone marrow-derived stromal cells (hBMSCs) were
seeded on those 3D ﬁber meshes scaffolds reinforced by nanoﬁbers
and sustain osteogenic differentiation, are adequate for bone tissue
engineering.
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